These significant findings strongly suggest the potential of CD19 CAR-T cells to maintain functionality over extended periods and selectively eliminate transferred autologous CD19+ B cells without detrimental effects on other B cell populations within the bone marrow of murine lupus. Here, CD19 is linked to systemic lupus erythematosus.